GO:0004656 procollagen-proline 4-dioxygenase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004656 describes the catalytic activity that converts procollagen L-proline to trans-4-hydroxy-L-proline, a modification essential for collagen triple-helix stability.
• The reaction requires 2-oxoglutarate, molecular oxygen, iron(II), and ascorbate, and produces succinate and CO2 as byproducts.
• Prolyl 4-hydroxylase is a tetrameric enzyme composed of alpha subunits (P4HA1, P4HA2, P4HA3) and a beta subunit (P4HB).
• P4HA1 and P4HA2 exhibit distinct sequence preferences for X-Pro-Gly triplets, influencing collagen subtype-specific hydroxylation.
• Dysregulation of prolyl 4-hydroxylase activity is implicated in cancer, fibrosis, and hypoxia-related diseases.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise dissection of P4HA gene function in health and disease.
Description
Procollagen-proline 4-dioxygenase activity (GO:0004656) is a molecular function that catalyzes the hydroxylation of proline residues in procollagen, a critical post-translational modification for collagen biosynthesis. This enzymatic activity is essential for the stability of the collagen triple helix, as hydroxyproline residues form hydrogen bonds that reinforce the structure. Researchers study this activity to understand connective tissue disorders, cancer progression, and fibrotic diseases, where collagen deposition and remodeling are dysregulated. The enzyme, also known as prolyl 4-hydroxylase, requires 2-oxoglutarate, oxygen, iron(II), and ascorbate as cofactors. Its role in oxygen sensing and metabolic reprogramming has been highlighted in cancer and hypoxia research. Understanding GO:0004656 provides insights into extracellular matrix biology and potential therapeutic targets.
procollagen-proline 4-dioxygenase activity At A Glance
| GO ID | GO:0004656 |
|---|---|
| GO term | procollagen-proline 4-dioxygenase activity |
| Ontology | molecular_function |
| Synonym | prolyl 4-hydroxylase activity; collagen proline hydroxylase activity; proline hydroxylase activity |
| Major function | Hydroxylation of proline residues in procollagen to form trans-4-hydroxy-L-proline |
| Cofactors | 2-oxoglutarate, O2, Fe(II), ascorbate |
| Byproducts | Succinate, CO2 |
| Subunit composition | Tetramer of alpha subunits (P4HA1/2/3) and beta subunit (P4HB) |
| Sequence specificity | P4HA1 and P4HA2 prefer different X-Pro-Gly triplets |
What Is GO:0004656?
GO:0004656, procollagen-proline 4-dioxygenase activity, is defined as the catalysis of the reaction: procollagen L-proline + 2-oxoglutarate + O2 = procollagen trans-4-hydroxy-L-proline + succinate + CO2. This activity hydroxylates proline residues in procollagen, a precursor of collagen, and is dependent on iron(II) and ascorbate.
Why Is procollagen-proline 4-dioxygenase activity Important in Cell Biology?
Procollagen-proline 4-dioxygenase activity is crucial for collagen synthesis and extracellular matrix integrity. Hydroxyproline formation stabilizes the collagen triple helix, and its dysregulation leads to connective tissue diseases, cancer, and fibrosis. The enzyme also links metabolism and oxygen sensing, as succinate, a byproduct, can inhibit HIF prolyl hydroxylases, affecting tumor growth.
• Essential for collagen triple-helix stability and connective tissue strength.
• Mutations or altered expression are linked to Ehlers-Danlos syndrome and other connective tissue disorders.
• Overexpression promotes tumor progression and metastasis in glioblastoma and bladder cancer.
• Succinate accumulation inhibits HIF prolyl hydroxylases, linking TCA cycle dysfunction to oncogenesis.
• Modulates hypoxia-inducible factor (HIF) activity and oxygen sensing.
• Target for antifibrotic and anticancer therapies.
• Isoform-specific functions influence collagen subtype composition.
• Required for proper wound healing and tissue remodeling.
• Involved in mechanotransduction signaling in cancer cells.
• Provides a model for studying 2-oxoglutarate-dependent dioxygenases.
What Happens During procollagen-proline 4-dioxygenase activity?
Substrate recognition and binding
In simple terms: The enzyme finds and grabs procollagen strands at specific proline sites.
Prolyl 4-hydroxylase recognizes procollagen sequences, particularly X-Pro-Gly triplets, and binds the proline residue to be hydroxylated. The alpha subunits P4HA1 and P4HA2 exhibit distinct preferences for different X residues, influencing which prolines are modified. This substrate specificity ensures proper hydroxylation patterns for different collagen types.
Catalytic hydroxylation
In simple terms: The enzyme adds an oxygen atom to proline, turning it into hydroxyproline.
The catalytic cycle involves oxidative decarboxylation of 2-oxoglutarate, with one oxygen atom incorporated into proline and the other into succinate. The reaction consumes O2 and produces CO2 and succinate. Iron(II) is essential for catalysis, and ascorbate maintains iron in its reduced state.
Cofactor requirements and regeneration
In simple terms: The enzyme needs iron and vitamin C to keep working.
Fe(II) is coordinated by conserved histidine and aspartate residues in the active site. Ascorbate is required to reduce Fe(III) back to Fe(II) after uncoupled decarboxylation, preventing enzyme inactivation. Without ascorbate, the enzyme loses activity, linking scurvy to defective collagen synthesis.
Product release and triple-helix stabilization
In simple terms: Hydroxyproline helps collagen twist into a strong rope.
After hydroxylation, trans-4-hydroxy-L-proline residues form hydrogen bonds that stabilize the collagen triple helix. This modification is critical for the secretion and structural integrity of collagen. Defects in hydroxylation lead to unstable collagen and connective tissue disorders.
Key Genes Involved in GO:0004656 procollagen-proline 4-dioxygenase activity
The following genes encode subunits and regulators of procollagen-proline 4-dioxygenase activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| P4HA1 | Catalytic alpha subunit; major isoform in most tissues | Overexpressed in glioblastoma; modulates succinate signaling |
| P4HA2 | Catalytic alpha subunit; distinct substrate specificity | Isoform-specific collagen hydroxylation |
| P4HA3 | Catalytic alpha subunit; less characterized | Potential role in cancer and fibrosis |
| P4HB | Beta subunit; protein disulfide isomerase | Essential for enzyme assembly and disulfide bond formation |
| HIF1A | Hypoxia-inducible factor 1-alpha | Regulates P4HA1 expression under hypoxia |
| ATF3 | Activating transcription factor 3 | Modulates P4HA1/succinate signaling in glioblastoma |
| PGK1 | Phosphoglycerate kinase 1 | Succinylation target affected by P4HA1 |
| GABPA | ETS transcription factor | Represses extracellular matrix deposition |
| VHL | von Hippel-Lindau tumor suppressor | Regulates HIF degradation via prolyl hydroxylation |
| EGLN1 | HIF prolyl hydroxylase 2 (PHD2) | Oxygen sensor; inhibited by succinate |
| EGLN2 | HIF prolyl hydroxylase 1 (PHD1) | Oxygen sensor; related to GO:0004656 |
| EGLN3 | HIF prolyl hydroxylase 3 (PHD3) | Oxygen sensor; related to GO:0004656 |
| SDHA | Succinate dehydrogenase subunit A | TCA cycle enzyme; mutations increase succinate |
| SDHB | Succinate dehydrogenase subunit B | TCA cycle enzyme; mutations increase succinate |
| SDHC | Succinate dehydrogenase subunit C | TCA cycle enzyme; mutations increase succinate |
| SDHD | Succinate dehydrogenase subunit D | TCA cycle enzyme; mutations increase succinate |
| COL1A1 | Type I collagen alpha-1 chain | Major substrate for prolyl 4-hydroxylation |
How Is procollagen-proline 4-dioxygenase activity Regulated?
Procollagen-proline 4-dioxygenase activity is regulated at multiple levels. Hypoxia-inducible factor 1-alpha (HIF1A) induces P4HA1 expression under low oxygen, linking hydroxylation to oxygen sensing. The transcription factor ATF3 modulates P4HA1 and succinate signaling in glioblastoma. Succinate, a byproduct, can inhibit HIF prolyl hydroxylases, creating a feedback loop between metabolism and hydroxylation. Ascorbate availability directly affects enzyme activity by maintaining iron in the reduced state. Additionally, the ETS transcription factor GABPA represses extracellular matrix deposition, indirectly affecting collagen hydroxylation.
procollagen-proline 4-dioxygenase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| P4HA1 | Glioblastoma progression | P4HA1 knockout glioma cell line |
| P4HA2 | Collagen subtype-specific fibrosis | P4HA2 point mutation knock-in |
| P4HB | Connective tissue disorders | P4HB knockout fibroblasts |
| SDHA | Paraganglioma/pheochromocytoma | SDHA knockout cells with succinate measurement |
| GABPA | Bladder cancer aggressiveness | GABPA overexpression in bladder cancer cells |
Cancer and tumor microenvironment
Prolyl 4-hydroxylase activity is upregulated in many cancers, promoting collagen deposition and tumor stiffness. In glioblastoma, P4HA1 modulates succinate signaling and affects PGK1 succinylation, influencing tumor metabolism. In bladder cancer, GABPA represses extracellular matrix deposition, and its loss increases aggressiveness. Succinate accumulation from TCA cycle mutations inhibits HIF prolyl hydroxylases, linking to oncogenesis.
Hypoxia and metabolic reprogramming
The enzyme is an oxygen sensor, and its activity is reduced under hypoxia. HIF prolyl hydroxylases (EGLN1-3) regulate HIF stability, and succinate inhibits these enzymes, mimicking hypoxia. This crosstalk is critical in cancer and ischemic diseases.
Connective tissue disorders
Defects in collagen prolyl hydroxylation cause connective tissue fragility. Ascorbate deficiency leads to scurvy, characterized by defective collagen synthesis. Mutations in P4HA1 or P4HB can cause Ehlers-Danlos-like syndromes.
From procollagen-proline 4-dioxygenase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does P4HA1 loss reduce tumor growth? | P4HA1 knockout in glioblastoma cell line |
| How does P4HA2 substrate specificity affect collagen composition? | P4HA2 point mutation knock-in in fibroblasts |
| Can P4HB be tagged for localization studies? | P4HB tagged knock-in in HEK293 cells |
| Does P4HA1 overexpression increase succinate? | P4HA1 overexpression in cancer cells |
| What is the effect of GABPA on ECM deposition? | GABPA knockout in bladder cancer cells |
| How does ascorbate affect prolyl hydroxylation? | P4HA1 knockout with ascorbate rescue |
How to Study the procollagen-proline 4-dioxygenase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Hydroxyproline assay | Hydroxylation level | Enzyme activity in cell lysates |
| RNA-seq | mRNA expression | P4HA1/2/3 and P4HB levels |
| Western blot | Protein expression | P4HA1 and P4HB protein levels |
| Mass spectrometry | Hydroxyproline and succinate | Post-translational modifications |
| CRISPR knockout | Gene function | P4HA1 loss in cancer cells |
| CRISPR knock-in | Tagged protein | P4HB localization |
| Immunohistochemistry | Tissue expression | Collagen deposition in tumors |
| Seahorse assay | Metabolic flux | Succinate production |
Enzymatic activity assays
Prolyl 4-hydroxylase activity can be measured using radiolabeled proline or by detecting hydroxyproline via mass spectrometry. These assays require 2-oxoglutarate, Fe(II), ascorbate, and oxygen.
Gene expression analysis
RNA-seq and qPCR quantify P4HA1, P4HA2, P4HA3, and P4HB mRNA levels under hypoxia or in cancer models.
Proteomics and post-translational modification
Mass spectrometry identifies hydroxyproline sites and succinylation events, such as PGK1 succinylation modulated by P4HA1.
CRISPR screening
Genome-wide CRISPR knockout screens can identify genes that modulate prolyl 4-hydroxylase activity or collagen deposition.
How CRISPR Can Be Used to Study GO:0004656 procollagen-proline 4-dioxygenase activity
Knockout
CRISPR knockout of P4HA1, P4HA2, or P4HB eliminates prolyl 4-hydroxylase activity, causing defective collagen synthesis. This is used to study cancer progression and fibrosis.
Point Mutation
Point mutations in the catalytic domain of P4HA1 or P4HA2 can abrogate enzyme activity or alter substrate specificity, helping dissect isoform-specific functions.
Knock-in
Knock-in of tagged P4HB or P4HA1 allows live-cell imaging and proteomic analysis of the enzyme complex.
Overexpression
Overexpression of P4HA1 increases hydroxylation and succinate production, mimicking cancer-associated metabolic changes.
How EDITGENE Supports procollagen-proline 4-dioxygenase activity Research
Researchers studying procollagen-proline 4-dioxygenase activity-related genes often need to determine whether a candidate gene is causally involved in collagen hydroxylation, cancer progression, or metabolic reprogramming. EDITGENE provides CRISPR-based cell models to validate gene function with precision.
Contact EDITGENE today to design your custom CRISPR model for procollagen-proline 4-dioxygenase activity research.
Frequently Asked Questions About procollagen-proline 4-dioxygenase activity
What is procollagen-proline 4-dioxygenase activity?
It is the enzymatic activity (GO:0004656) that hydroxylates proline residues in procollagen, forming trans-4-hydroxy-L-proline, which is essential for collagen stability.
What genes are involved in procollagen-proline 4-dioxygenase activity?
The main genes are P4HA1, P4HA2, P4HA3 (alpha subunits) and P4HB (beta subunit), which assemble into the prolyl 4-hydroxylase tetramer.
What cofactors are required for prolyl 4-hydroxylase?
The enzyme requires 2-oxoglutarate, molecular oxygen, iron(II), and ascorbate.
How is prolyl 4-hydroxylase related to cancer?
Overexpression of P4HA1 promotes tumor progression and modulates succinate signaling in glioblastoma and other cancers.
What diseases are associated with defective prolyl 4-hydroxylase?
Defects cause connective tissue disorders like Ehlers-Danlos syndrome, and scurvy results from ascorbate deficiency.
How can I study prolyl 4-hydroxylase activity in the lab?
Use enzymatic assays, CRISPR knockout models, RNA-seq, and mass spectrometry to measure hydroxyproline and succinate.
What is the difference between P4HA1 and P4HA2?
They are distinct alpha subunits with different substrate specificities for X-Pro-Gly triplets in collagen.
Does hypoxia affect prolyl 4-hydroxylase activity?
Yes, hypoxia reduces activity and induces P4HA1 expression via HIF1A, linking to oxygen sensing.
What is the role of succinate in prolyl 4-hydroxylase regulation?
Succinate, a byproduct, inhibits HIF prolyl hydroxylases, creating a feedback loop between metabolism and hydroxylation.
Can CRISPR be used to model prolyl 4-hydroxylase dysfunction?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are available to study gene function.
Conclusion
Procollagen-proline 4-dioxygenase activity (GO:0004656) is a fundamental enzymatic function in collagen biosynthesis, with critical roles in connective tissue integrity, cancer, and oxygen sensing. Understanding its mechanism and regulation provides insights into human diseases and potential therapeutic targets. CRISPR-based models offer powerful tools to dissect the roles of P4HA genes and their regulators.
References
- 1. Yang S et al.. 2024. HIF1α/ATF3 partake in PGK1 K191/K192 succinylation by modulating P4HA1/succinate signaling in glioblastoma.. Neuro Oncol 26(8):1405-1420 PMID: 38441561
- 2. Selak MA et al.. 2005. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase.. Cancer Cell 7(1):77-85 PMID: 15652751
- 3. Salo AM et al.. 2024. Collagen prolyl 4-hydroxylase isoenzymes I and II have sequence specificity towards different X-Pro-Gly triplets.. Matrix Biol 125:73-87 PMID: 38081527
- 4. Brahimi-Horn C et al.. 2006. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.. Bull Cancer 93(8):E73-80 PMID: 16935775
- 5. Cardinale GJ et al.. 1974. Prolyl hydroxylase.. Adv Enzymol Relat Areas Mol Biol 41(0):245-300 PMID: 4371784
- 6. Dai M et al.. 2025. The ETS transcription factor GABPA inhibits bladder cancer aggressiveness by repressing extracellular matrix deposition and mechanotransduction signaling.. Cell Death Dis 16(1):618 PMID: 40813762
- 8. Chandel NS. 2010. Mitochondrial regulation of oxygen sensing.. Adv Exp Med Biol 661:339-54 PMID: 20204741
